Ninth Annual Controversies in Breast Cancer: Adjuvant and Neoadjuvant Therapy
Sheraton New York Hotel & Towers
New York, NY
October 8-10, 2010
| 7:30 am | Registration and Continental Breakfast |
| 8:00 am | Welcome and Introductions |
| Breast Cancer Molecular Pathology | |
| 8:05 am | Presession Survey |
| 8:10 am | Discoveries From Breast Cancer Sequencing Elaine Mardis |
| 8:30 am | Pathways Driving Aggressive Breast Cancer Philippe Bedard |
| 8:50 am | Tumor Size: Biology and Prognosis William Foulkes |
| 9:10 am | Targeting Metastasis Andrea Richardson |
| 9:30 am | Postsession Survey |
| 9:35 am | Panel Discussion |
| 10:00 am | Break |
| Indolent ER-Positive Breast Cancer | |
| 10:20 am | Presession Survey |
| 10:25 am | Biology of Luminal Breast Cancer William F. Symmans |
| 10:45 am | Predictors of Favorable Biology Stephen Chia |
| Chemotherapy Should Be Avoided in Luminal Breast Cancer |
|
| 11:05 am | Point Kathy Albain |
| 11:25 am | Counterpoint Charles E. Geyer, Jr |
| 11:45 am | Panel Discussion |
| 12:10 pm | Lunch |
| Indolent ER-Positive Breast Cancer (continued) | |
| Optimizing Endocrine Therapy |
|
| 1:10 pm | Premenopausal Lori J. Goldstein |
| 1:30 pm | Postmenopausal Edward Romond |
| 1:50 pm | Preoperative Endocrine Therapy: Emerging Insights Steven Come |
| 2:10 pm | Postsession Survey |
| 2:15 pm | Panel Discussion |
| 2:40 pm | Break |
| Aggressive ER-Positive Breast Cancer | |
| 3:00 pm | Presession Survey |
| 3:05 pm | Escape Mechanisms From Endocrine Therapy C. Kent Osborne |
| 3:25 pm | Optimizing Adjuvant Chemotherapy for Luminal Breast Cancer Jo Anne Zujewski |
| 3:45 pm | Novel Cytotoxic Agents for Aggressive Breast Cancer Joyce O'Shaughnessy |
| 4:05 pm | Adjuvant Breast Cancer Therapy: Hypotheses for the Future Clifford Hudis |
| 4:25 pm | Postsession Survey |
| 4:30 pm | Panel Discussion |
| 4:55 pm | Adjourn |